These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 24917751)

  • 21. The biodegradable self-reinforced poly-DL-lactic acid spiral stent compared with a suprapubic catheter in the treatment of post-operative urinary retention after visual laser ablation of the prostate.
    Pétas A; Talja M; Tammela TL; Taari K; Välimaa T; Törmälä P
    Br J Urol; 1997 Sep; 80(3):439-43. PubMed ID: 9313664
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The bell-shaped nitinol prostatic stent in the treatment of lower urinary tract symptoms: experience in 108 patients.
    van Dijk MM; Mochtar CA; Wijkstra H; Laguna MP; de la Rosette JJ
    Eur Urol; 2006 Feb; 49(2):353-9. PubMed ID: 16426738
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Influence of baseline variables on changes in International Prostate Symptom Score after combined therapy with dutasteride plus tamsulosin or either monotherapy in patients with benign prostatic hyperplasia and lower urinary tract symptoms: 4-year results of the CombAT study.
    Roehrborn CG; Barkin J; Tubaro A; Emberton M; Wilson TH; Brotherton BJ; Castro R
    BJU Int; 2014 Apr; 113(4):623-35. PubMed ID: 24127818
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term outcome of prostatic stent treatment for benign prostatic hyperplasia.
    Chiou RK; Chen WS; Akbari A; Foley S; Lynch B; Taylor RJ
    Urology; 1996 Oct; 48(4):589-93. PubMed ID: 8886065
    [TBL] [Abstract][Full Text] [Related]  

  • 25. International Prostatic Symptom Score-voiding/storage subscore ratio in association with total prostatic volume and maximum flow rate is diagnostic of bladder outlet-related lower urinary tract dysfunction in men with lower urinary tract symptoms.
    Jiang YH; Lin VC; Liao CH; Kuo HC
    PLoS One; 2013; 8(3):e59176. PubMed ID: 23527124
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of urethral instrumentation on uroflowmetry.
    Issa MM; Chun T; Thwaites D; Bouet R; Hall J; Miller LE; Ritenour CW
    BJU Int; 2003 Sep; 92(4):426-8. PubMed ID: 12930434
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Obstructive voiding symptoms following stereotactic body radiation therapy for prostate cancer.
    Arscott WT; Chen LN; Wilson N; Bhagat A; Kim JS; Moures RA; Yung TM; Lei S; Collins BT; Kowalczyk K; Suy S; Dritschilo A; Lynch JH; Collins SP
    Radiat Oncol; 2014 Jul; 9():163. PubMed ID: 25056726
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of continence following 532 nm laser prostatectomy for patients previously treated with radiation therapy or brachytherapy.
    No D; Osterberg EC; Otto B; Naftali I; Choi B
    Lasers Surg Med; 2013 Aug; 45(6):358-61. PubMed ID: 23813669
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Prevention of temporary prostatic obstruction after high-energy microwave thermothery by placement of prostatic bridge catheter].
    Djavan B; Seitz C; Fakhari M; Ghawidel K; Marberger M
    Prog Urol; 1999 Apr; 9(2):261-70. PubMed ID: 10370950
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Minimal channel GreenLight photovaporization before permanent implant prostate brachytherapy for patients with obstructive symptoms: Technically feasible and safe.
    Peigne C; Fournier G; Dissaux G; Delage F; Coquet JB; Boussion N; Goasduff G; Malhaire JP; Pradier O; Schick U; Valeri A
    Brachytherapy; 2021; 20(1):50-57. PubMed ID: 32891570
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Early voiding dysfunction associated with prostate brachytherapy.
    Wagner TT; Nag S; Young D; Bahnson RR
    Urol Oncol; 2000 Dec; 6(1):20-23. PubMed ID: 11113369
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prophylactic versus therapeutic alpha-blockers after permanent prostate brachytherapy.
    Merrick GS; Butler WM; Wallner KE; Lief JH; Galbreath RW
    Urology; 2002 Oct; 60(4):650-5. PubMed ID: 12385927
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of tamsulosin on lower urinary tract symptoms due to double-J stent: a prospective study.
    Wang CJ; Huang SW; Chang CH
    Urol Int; 2009; 83(1):66-9. PubMed ID: 19641362
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The influence of isotope and prostate volume on urinary morbidity after prostate brachytherapy.
    Niehaus A; Merrick GS; Butler WM; Wallner KE; Allen ZA; Galbreath RW; Adamovich E
    Int J Radiat Oncol Biol Phys; 2006 Jan; 64(1):136-43. PubMed ID: 16198062
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transurethral electrovaporization-resection of the prostate using the "wing" cutting electrode: preliminary results of safety and efficacy in the treatment of men with prostatic outflow obstruction.
    Talic RF
    Urology; 1999 Jan; 53(1):106-10. PubMed ID: 9886597
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Transurethral laser ablation of the prostate in high risk patients with obstructive benign prostatic hyperplasia. Perioperative morbidity and 6 month outcome in 72 patients].
    Miller J; Erkens U; Fischer C; Klötzer JP; Weidner W
    Urologe A; 1997 Mar; 36(2):165-72. PubMed ID: 9199046
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Temporal resolution of urinary morbidity following prostate brachytherapy.
    Merrick GS; Butler WM; Lief JH; Dorsey AT
    Int J Radiat Oncol Biol Phys; 2000 Apr; 47(1):121-8. PubMed ID: 10758313
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tamsulosin efficiency in treatment of benign prostatic hyperplasia evaluated by determining bladder weight.
    Milicevic S
    Med Arch; 2012; 66(6):391-5. PubMed ID: 23409519
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Second-generation of temporary implantable nitinol device for the relief of lower urinary tract symptoms due to benign prostatic hyperplasia: results of a prospective, multicentre study at 1 year of follow-up.
    Porpiglia F; Fiori C; Amparore D; Kadner G; Manit A; Valerio M; Nicolaas L; Ho BSH; Alonso S; Schulman C; Barber N
    BJU Int; 2019 Jun; 123(6):1061-1069. PubMed ID: 30382600
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tadalafil Improves Symptoms, Erectile Function and Quality of Life in Patients with Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia (KYU-PRO Study).
    Takahashi R; Miyazato M; Nishii H; Sumino Y; Takayama K; Onzuka M; Oshiro T; Saito S; Fujimoto N; Mimata H; Eto M
    Low Urin Tract Symptoms; 2018 Jan; 10(1):76-83. PubMed ID: 29341501
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.